Publicaciones en las que colabora con Ana Moya Álvarez (7)

2021

  1. Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 953-961

2020

  1. Bedtime hypertension chronotherapy best reduces cardiovascular disease risk as corroborated by the Hygia Chronotherapy Trial. Rebuttal to European Society of Hypertension officials.

    Chronobiology International, pp. 1-10

  2. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial

    European heart journal, Vol. 41, Núm. 48, pp. 4565-4576

2019

  1. Asleep (not night-time) blood pressure as prognostic marker of cardiovascular risk

    European Heart Journal

2018

  1. Asleep blood pressure: Significant prognostic marker of vascular risk and therapeutic target for prevention

    European Heart Journal, Vol. 39, Núm. 47, pp. 4159-4171

2013

  1. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes

    Chronobiology International, Vol. 30, Núm. 1-2, pp. 99-115

  2. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension

    Chronobiology International, Vol. 30, Núm. 1-2, pp. 192-206